Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment.

Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment.

BACKGROUND: Chronic heart failure (CHF) is a major cause of morbidity and mortality that requires a novel approach to therapy. Perhexiline is an antianginal drug that augments glucose metabolism by blocking muscle mitochondrial free fatty acid uptake, thereby increasing metabolic efficiency. We asse...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Lee, L, Campbell, R, Scheuermann-Freestone, M, Taylor, R, Gunaruwan, P, Williams, L, Ashrafian, H, Horowitz, J, Fraser, A, Clarke, K, Frenneaux, M
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2005

समान संसाधन

Augmentation of glucose metabolism with perhexiline in non-ischaemic heart failure
द्वारा: Lee, L, और अन्य
प्रकाशित: (2004)

Perhexiline.
द्वारा: Ashrafian, H, और अन्य
प्रकाशित: (2007)

Effects of perhexiline on ketone body and triglyceride synthesis in patients with refractory angina or heart failure
द्वारा: Shivu, G, और अन्य
प्रकाशित: (2008)

Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy.
द्वारा: Abozguia, K, और अन्य
प्रकाशित: (2010)

Metabolic Modulation With Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy
द्वारा: Abozguia, K, और अन्य
प्रकाशित: (2009)

Metabolic modulation in heart failure: the coming of age.
द्वारा: Ashrafian, H, और अन्य
प्रकाशित: (2007)

The pathophysiology of heart failure: a tale of two old paradigms revisited.
द्वारा: Ashrafian, H, और अन्य
प्रकाशित: (2008)

Metabolic mechanisms in heart failure.
द्वारा: Ashrafian, H, और अन्य
प्रकाशित: (2007)

METABOLIC ALTERATION IN HYPERTROPHIC CARDIOMYOPATHY (METAL-HCM STUDY): RANDOMISED DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OF PERHEXILINE THERAPY IN PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
द्वारा: Abozguia, K, और अन्य
प्रकाशित: (2010)

Changes in the cardiac metabolome caused by perhexiline treatment in a mouse model of hypertrophic cardiomyopathy.
द्वारा: Gehmlich, K, और अन्य
प्रकाशित: (2014)

Abnormal cardiac and skeletal muscle function and energetics correlate with insulin resistance in heart failure
द्वारा: Scheuermann-Freestone, M, और अन्य
प्रकाशित: (2004)

Impaired energetics in heart failure - a new therapeutic target.
द्वारा: Ormerod, J, और अन्य
प्रकाशित: (2008)

Perhexiline Therapy in Patients with Type 2 Diabetes: Incremental Insulin Resistance despite Potentiation of Nitric Oxide Signaling
द्वारा: Cher-Rin Chong, और अन्य
प्रकाशित: (2022-09-01)

Prevalence of heart failure preserved ejection fraction in the community
द्वारा: Mahadevan, G, और अन्य
प्रकाशित: (2007)

Modification of myocardial substrate use as a therapy for heart failure.
द्वारा: Abozguia, K, और अन्य
प्रकाशित: (2006)

Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation
द्वारा: Bimala Dhakal, और अन्य
प्रकाशित: (2023-03-01)

Hypoxic modulation of exogenous nitrite-induced vasodilation in humans.
द्वारा: Maher, A, और अन्य
प्रकाशित: (2008)

Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo
द्वारा: Gabriela Reyes-Castellanos, और अन्य
प्रकाशित: (2023-06-01)

Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects
द्वारा: Bimala Dhakal, और अन्य
प्रकाशित: (2023-04-01)

Systemic nitrite selectively dilates veins and pulmonary vasculature, relieving diastolic ventricular interaction in advanced heart failure
द्वारा: Ormerod, J, और अन्य
प्रकाशित: (2009)

Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy
द्वारा: Tobias J. Pfeffer, और अन्य
प्रकाशित: (2021-08-01)

Abnormal cardiac high-energy phosphate metabolism in a patient with type 2 diabetes mellitus.
द्वारा: Scheuermann-Freestone, M, और अन्य
प्रकाशित: (2006)

Metabolic modulation in heart failure: high time for a definitive clinical trial.
द्वारा: Ashrafian, H, और अन्य
प्रकाशित: (2011)

Effect of chronic peroxisome proliferator-activated receptor gamma (PPAR gamma) activation on cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes mellitus
द्वारा: Scheuermann-Freestone, M, और अन्य
प्रकाशित: (2004)

Pacing in congestive heart failure
द्वारा: Frenneaux Michael P, और अन्य
प्रकाशित: (2000-10-01)

The pathophysiology of heart failure
द्वारा: Ashrafian, H, और अन्य
प्रकाशित: (2002)

DYNAMIC CHANGES IN LEFT VENTRICULAR FUNCTION ON EXERCISE IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE ROLE OF MYOCARDIAL ENERGY DEFICIENCY
द्वारा: Phan, T, और अन्य
प्रकाशित: (2009)

Cardiac and skeletal muscle metabolism after chronic PPAR gamma activation in type 2 diabetes mellitus
द्वारा: Scheuermann-Freestone, M, और अन्य
प्रकाशित: (2004)

Cardiac energetics in congestive heart failure.
द्वारा: Ashrafian, H
प्रकाशित: (2002)

Response to letter regarding article, "The effect of selective heart rate slowing in heart failure with preserved ejection fraction"
द्वारा: Pal, N, और अन्य
प्रकाशित: (2016)

Impaired active relaxation during dynamic exercise in patients with heart failure with a preserved ejection fraction (HfpEF)
द्वारा: Phan, T, और अन्य
प्रकाशित: (2008)

Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency.
द्वारा: Phan, T, और अन्य
प्रकाशित: (2009)

Chronic oral ascorbic acid therapy worsens skeletal muscle metabolism in patients with chronic heart failure.
द्वारा: Nightingale, A, और अन्य
प्रकाशित: (2007)

Genetic cardiomyopathies causing heart failure.
द्वारा: Cahill, T, और अन्य
प्रकाशित: (2013)

New therapies for heart failure: is thalidomide the answer?
द्वारा: Davey, P, और अन्य
प्रकाशित: (2000)

Despite improving endothelial function oral vitamin C increases phosphocreatine depletion during exercise in patients with chronic heart failure
द्वारा: Nightingale, A, और अन्य
प्रकाशित: (2002)

Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
द्वारा: Alessandra Guidi, और अन्य
प्रकाशित: (2016-08-01)

Modulation of cardiac energetics as a target in ischemic heart disease
द्वारा: Ashrafian, H
प्रकाशित: (2011)

Haemoglobin and flow-mediated vasodilation.
द्वारा: Madsen, P, और अन्य
प्रकाशित: (2006)

PPARgamma activation improves cardiac energy metabolism in patients with type 2 diabetes Mellitus
द्वारा: Scheuermann-Freestone, M, और अन्य
प्रकाशित: (2003)